IGHG3 and myalgic encephalomeyelitis/chronic fatigue syndrome: Moreover, in patients with concurrent ME/CFS, we identified notably elevated levels of IgG3 and IgG4, suggesting immune dysregulation as a potential risk factor for severe disease courses.